Journal
ANNUAL REVIEW OF MEDICINE
Volume 56, Issue -, Pages 213-223Publisher
ANNUAL REVIEWS
DOI: 10.1146/annurev.med.54.101601.152349
Keywords
cytotoxic T lymphocytes; nonhuman primate models; HIV immunity; DNA vaccines; live recombinant vectors
Categories
Ask authors/readers for more resources
The development of an HIV vaccine is proving to be an unprecedented challenge. The difficulty in creating this vaccine arises from the enormous genetic variation of the virus and the unusual importance of cytotoxic T lymphocytes (CTL) in controlling its spread. Whereas traditional vaccine strategies are unlikely to confer safe and effective HIV protection, novel strategies for eliciting CTL have provided substantial clinical benefits in nonhuman primate model systems. These vaccine strategies, including plasmid DNA and live recombinant vectors, are currently being evaluated in human clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available